Search Results

[Efficacy and survival analysis of DICE regimen for 97 patients with relapsed or refractory Non-Hodgkin's lymphoma].

• Authors : Ping LY; Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education) , Peking University School of Clinical Oncology, Beijing Cancer Hospital, Beijing Institute for Cancer Research, Beijing 100142, China.; Song YQ

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Lymphoma, Non-Hodgkin/Lymphoma, Non-Hodgkin/Lymphoma, Non-Hodgkin/*drug therapy; Cisplatin/Cisplatin/Cisplatin/administration & dosage

• Source: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi [Zhonghua Xue Ye Xue Za Zhi] 2016 Sep 14; Vol. 37 (9), pp. 790-794.Publisher: Chinese Medical Association Country of Publication: China NLM ID: 8212398 Publication Model: Print Cited Medium:

Record details

[Efficacy Analysis of GEMOX Regimen for Treatment of Refractory Non-Hodgkin's Lymphoma].

• Authors : Yan SB; Department of Hematology, Yishui Central Hospital of Linyi, Linyi 276400, Shandong Province,China.; Chen ZG

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Lymphoma, Non-Hodgkin/Lymphoma, Non-Hodgkin/Lymphoma, Non-Hodgkin/*drug therapy; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/administration & dosage gemcitabine-oxaliplatin regimen

• Source: Zhongguo shi yan xue ye xue za zhi [Zhongguo Shi Yan Xue Ye Xue Za Zhi] 2017 Oct; Vol. 25 (5), pp. 1415-1419.Publisher: Zhongguo shi yan xue za zhi she Country of Publication: China NLM ID: 101084424 Publication Model: Print Cited Medium: Print ISSN:

Record details

影响Ⅲ 期食管癌术后患者预后的因素.

• Authors : 杨琼; 王玉祥; 何明

• Source: Chinese Journal of Oncology; 7/23/2016, Vol. 38 Issue 7, p530-537, 8p

Record details

[Clinical study of COAD-B regimen in treatment of patients with relapsed/refractory non-Hodgkin lymphoma].

• Authors : Li MH; Department of Hematopathy, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.; Li YF

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Lymphoma, Non-Hodgkin/Lymphoma, Non-Hodgkin/Lymphoma, Non-Hodgkin/*drug therapy; Bleomycin/Bleomycin/Bleomycin/administration & dosage

• Source: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi [Zhonghua Xue Ye Xue Za Zhi] 2013 Oct; Vol. 34 (10), pp. 857-61.Publisher: Chinese Medical Association Country of Publication: China NLM ID: 8212398 Publication Model: Print Cited Medium:

Record details

[Efficacy and safety evaluation of gemcitabine combined with oxaliplatin in lymphoma patients after failure of multiple chemotherapy regimens].

• Authors : Yang J; Department of Medical Oncology, Cancer Institute/Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College; Beijing Key Laboratory of Clinical Research of Anti-Cancer Targeted Drugs. Beijing 100021, China.

Subjects: Salvage Therapy*; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Deoxycytidine/Deoxycytidine/Deoxycytidine/*analogs & derivatives gemcitabine-oxaliplatin regimen

• Source: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2014 Feb; Vol. 36 (2), pp. 137-40.Publisher: Chinese Medical Association Country of Publication: China NLM ID: 7910681 Publication Model: Print Cited Medium:

Record details

[Prognosis of primary non-Hodgkin's lymphoma of the breast].

• Authors : Guo HY; Department of Medical Oncology, Cancer Hospital, Shanghai Medical College, Fudan University, Shanghai 200032, China.; Zhao XM

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Breast Neoplasms/Breast Neoplasms/Breast Neoplasms/*drug therapy ; Lymphoma, Non-Hodgkin/Lymphoma, Non-Hodgkin/Lymphoma, Non-Hodgkin/*drug therapyCHOP protocol

• Source: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2008 Mar; Vol. 30 (3), pp. 200-2.Publisher: Chinese Medical Association Country of Publication: China NLM ID: 7910681 Publication Model: Print Cited Medium:

Record details

[Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].

• Authors : Zou GR; State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, 510060, P. R. China.; Zhang YJ

Subjects: Lymphoma, Non-Hodgkin*/Lymphoma, Non-Hodgkin*/Lymphoma, Non-Hodgkin*/drug therapy ; Lymphoma, Non-Hodgkin*/Lymphoma, Non-Hodgkin*/Lymphoma, Non-Hodgkin*/pathology ; Lymphoma, Non-Hodgkin*/Lymphoma, Non-Hodgkin*/Lymphoma, Non-Hodgkin*/radiotherapy CHOP protocol

• Source: Ai zheng = Aizheng = Chinese journal of cancer [Ai Zheng] 2006 Dec; Vol. 25 (12), pp. 1543-9.Publisher: Zhongshan da xue zhong liu fang zhi zhong xin Country of Publication: China NLM ID: 9424852 Publication Model: Print Cited Medium: Print

Record details

[Clinical features of 89 patients with primary non-Hodgkin's lymphoma of the tonsil].

• Authors : Qin Y; Department of Medical Oncology, Cancer Hospital/Cancer Institute, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100021, P. R. China.; Shi YK

Subjects: Lymphoma, Non-Hodgkin*/Lymphoma, Non-Hodgkin*/Lymphoma, Non-Hodgkin*/drug therapy ; Lymphoma, Non-Hodgkin*/Lymphoma, Non-Hodgkin*/Lymphoma, Non-Hodgkin*/pathology ; Lymphoma, Non-Hodgkin*/Lymphoma, Non-Hodgkin*/Lymphoma, Non-Hodgkin*/radiotherapy CHOP protocol

• Source: Ai zheng = Aizheng = Chinese journal of cancer [Ai Zheng] 2006 Apr; Vol. 25 (4), pp. 481-5.Publisher: Zhongshan da xue zhong liu fang zhi zhong xin Country of Publication: China NLM ID: 9424852 Publication Model: Print Cited Medium: Print

Record details

[Efficacy of modified Hyper-CVAD regimen on non-Hodgkin's lymphoma and safety evaluation].

• Authors : Shi W; Department of Medical Oncology, Cancer Institute/Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100021, P. R. China.; Shi YK

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Lymphoma, Non-Hodgkin/Lymphoma, Non-Hodgkin/Lymphoma, Non-Hodgkin/*drug therapy ; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/*drug therapyCVAD protocol

• Source: Ai zheng = Aizheng = Chinese journal of cancer [Ai Zheng] 2009 Oct; Vol. 28 (10), pp. 1083-7.Publisher: Zhongshan da xue zhong liu fang zhi zhong xin Country of Publication: China NLM ID: 9424852 Publication Model: Print Cited Medium: Print

Record details

[Efficacy of GDP regimen (gemcitabine, dexamethasone, and cisplatin) on relapsed or refractory aggressive non-Hodgkin's Lymphoma: a report of 24 cases].

• Authors : Fan Y; Department of Chemotherapy, Zhejiang Provincial Tumor Hospital, Hangzhou, Zhejiang, China. ; Huang ZY

Subjects: Drug Resistance, Multiple* ; Drug Resistance, Neoplasm*; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use GDP protocol

• Source: Ai zheng = Aizheng = Chinese journal of cancer [Ai Zheng] 2008 Nov; Vol. 27 (11), pp. 1222-5.Publisher: Zhongshan da xue zhong liu fang zhi zhong xin Country of Publication: China NLM ID: 9424852 Publication Model: Print Cited Medium: Print

Record details